Hiroto Inaba
St. Jude Children's Research Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Hiroto Inaba as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 17:58 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT06177067 · Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid LeukemiaSt. Jude Children's Research Hospital · recruiting · Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Acute Leukemia of Ambiguous Lineage · principal investigator
- Ph2NCT05955261 · A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid LeukemiaSt. Jude Children's Research Hospital · recruiting · Acute Myeloid Leukemia · principal investigator
- Ph2/Ph3NCT03117751 · Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and LymphomaSt. Jude Children's Research Hospital · active not recruiting · Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma · principal investigator
- Ph1NCT02270788 · Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic MalignanciesSt. Jude Children's Research Hospital · completed · Acute Myeloid Leukemia · principal investigator
- Ph2NCT01451515 · NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic LymphomaSt. Jude Children's Research Hospital · completed · Lymphoblastic Lymphoma · principal investigator
- Ph1NCT00908167 · Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic MalignanciesSt. Jude Children's Research Hospital · completed · Acute Myeloid Leukemia, Infantile Leukemia (Both AML and ALL), Myelodysplastic Syndrome · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 17:58 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Tyrosine kinase inhibitors for the treatment of childhood AMLR01CA138744 · NCI · OHIO STATE UNIVERSITY · PI Sharyn D Baker · fiscal years 2010 to 2019Named on NCT00908167
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 17:58 UTC. The ranking covers the 200 most relevant of 48 PubMed records, and a shared surname and initials can bring in a namesake. All 48 on PubMed
- Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial.Lancet Oncol · 2010471 citationsRCR 11.6
- Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16.J Clin Oncol · 2019243 citationsRCR 10.3
- Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study.Lancet Oncol · 2015178 citationsRCR 5.1
- 128 citationsRCR 3.3
- Improved prognosis for older adolescents with acute lymphoblastic leukemia.J Clin Oncol · 2011107 citationsRCR 2.7
- A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia.J Immunother Cancer · 201998 citationsRCR 3.5
- Skeletal, neuromuscular and fitness impairments among children with newly diagnosed acute lymphoblastic leukemia.Leuk Lymphoma · 201585 citationsRCR 3.4
- 83 citationsRCR 2.2
- Changes in body mass index, height, and weight in children during and after therapy for acute lymphoblastic leukemia.Cancer · 201860 citationsRCR 2.3
- Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL.Blood Adv · 202259 citationsRCR 3.6